On not jumping the gun: Ethical aspects of APOE gene testing for Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 111-119

  Post, Stephen G ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLINERGIC RECEPTOR STIMULATING AGENT; TACRINE;

ALZHEIMER DISEASE; CLINICAL GENETICS; CONFERENCE PAPER; CONFIDENTIALITY; GENETIC SCREENING; GENOTYPE; HUMAN; MEDICAL ETHICS; MEDICAL GENETICS;

EID: 0030475122     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32604.x     Document Type: Conference Paper

References (32)

1. HARDY, J. 1993. Genetic mistakes point the way for Alzheimer's disease. J. NIH Res. 5: 46-49.
2. ROSES, A. D. 1995. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38: 6-14.
3. FARRER, L., et al. 1995. Statement on the use of apolipoprotein E testing for Alzheimer disease. JAMA 274: 1627-1629.
4. BRODATY, H., et al. 1995. Consensus statement on predictive testing. Alzh. Dis. Assoc. Disord. 9: 182-187.
5. MAYEUX, R. 1995. Apolipoprotein E and Alzheimer's disease: The implications of progress in molecular medicine. Am. J. Pub. Health 85: 1280-1284.
6. BIRD, T. D. 1995. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: A cautionary view. Ann. Neurol. 38: 2-4.
7. NELKIN, D. & M. S. LINDEE. 1995. The DNA Mystique: The Gene as a Cultural Icon. W. H. Freeman Press. New York.
8. MIRINGOFF, M.-L. 1991. Social Costs of Genetic Welfare. Rutgers University Press. New Brunswick, NJ.
9. RODWIN, M. A. 1993. Medicine, Money, & Morals. Oxford University Press. New York.
10. RODWIN, M. A. 1992. The organized American medical profession's response to financial conflicts of interest: 1890-1992. Milbank Q. 70: 703-39.
11. COUNCIL ON SCIENTIFIC AFFAIRS AND COUNCIL ON ETHICAL AND JUDICIAL AFFAIRS. 1990. Conflicts of interest in medical center/industry research relationships. JAMA 263: 2790-2764.
12. THOMPSON, D. F. 1993. Understanding financial conflicts of interest. N. Engl. J. Med. 329: 573-576.
13. BLUMENTHAL, D. 1992. Academic-industry relationships in the life sciences: Extent, consequences, and management. JAMA 268: 3344-3349.
14. BLUMENTHAL, D. 1994. Growing pains for new academic/industry relationships. Health Affairs 13(3): 176-193.
15. WATSON, T. JULY 1995. Stalking Alzheimer's genes. US News World Rep. 119(2): 46-47.
16. HUBBARD, R. & E. WALD. 1993. Exploding the Gene Myth. Beacon Press. Boston.
17. FOLEY, J. M. 1993. Marginal to useless medications. Centerviews 7(2): 1, 4.
18. JUENGNST, E. T. 1995. The ethics of prediction: Genetic risk and the physician-patient relationship. Genome Sci. Technol. 1: 21-36.
19. ANNAS, G. J. 1995. Genetic prophecy and genetic privacy-can we prevent the dream from becoming a nightmare? Am. J. Pub. Health 85: 1196-1197.
20. WESTIN, A. F. 1994. Privacy and genetic information: A sociopolitical analysis. In The Genetic Frontier: Ethics, Law, and Policy. M. S. Frankel & A. Teich, Eds.: 53-76. American Association for the Advancement of Science. Washington, DC.
21. POWERS, M. 1994. Privacy and the control of genetic information. In The Genetic Frontier: Ethics, Law, and Policy. M. S. Frankel & A. Teich, Eds.: 77-100. American Association for the Advancement of Science. Washington, DC.
22. PRESIDENT'S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND BIOMEDICAL AND BEHAVIORAL RESEARCH. 1983. Screening and Counseling for Genetic Conditions: A Report on the Ethical. Social, and Legal Implications of Genetic Screening, Counseling, and Educations Programs. U.S. Government Printing Office. Washington, DC.
23. NATIONAL INSTITUTES OF HEALTH. 1993. Genetic Information and Health Insurance: Report of the Task Force on Genetic Information and Insurance (NIH Publication No. 93-3686). U.S. Department of Health and Human Services. Washington, DC.
24. POKORSKI, R. J. 1994. Use of genetic information by private insurers. In Justice and the Human Genome Project. T. F. Murphy & M. A. Lappe. Eds.: 91-109. University of California Press. Berkeley, CA.
25. DANIELS, N. 1994. The genome project, individual differences, and just health care. In Justice and the Human Genome Project. T. F. Murphy & M. A. Lappe, Eds.: 110-132. University of California Press. Berkeley, CA.
26. NELKIN, D. & L. TANCREDI. 1989. Dangerous Diagnostics: The Social Power of Biological Information. Basic Books. New York.
27. ANNAS, G. 1993. Privacy rules for DNA databanks: Protecting coded "future diaries." JAMA 270: 2346-2350.
28. CALLAHAN, D. 1993. The Troubled Dream of Life: Living with Mortality. Simon & Schuster. New York.
29. FLECK, L. M. 1994. Just genetics: A problem agenda. In Justice and the Human Genome Project. T. F. Murphy & M. A. Lappe, Eds.: 133-152. University of California Press. Berkeley, CA.
30. COUNCIL ON ETHICAL AND JUDICIAL AFFAIRS OF THE AMERICAN MEDICAL ASSOCIATION. 1995. Ethical issues in managed care. JAMA 273: 330-335.
31. MENZEL, P. T. 1990. Strong Medicine: The Ethical Rationing of Health Care. Oxford University Press. New York.
32. POST, S. G. 1995. The Moral Challenge of Alzheimer Disease. Johns Hopkins University Press. Baltimore, MD.